Cargando…
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?
PARP inhibitors have proven to be effective in conjunction with conventional therapeutics in the treatment of various solid as well as hematologic malignancies, particularly when the tumors are deficient in DNA repair pathways. However, as the case with other chemotherapeutic agents, their effective...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tech Science Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208061/ https://www.ncbi.nlm.nih.gov/pubmed/37304006 http://dx.doi.org/10.32604/or.2022.026459 |